Article ID Journal Published Year Pages File Type
4005277 American Journal of Ophthalmology 2006 4 Pages PDF
Abstract
A single dose of intravitreal pegaptanib was not effective in these two patients at six weeks. This report reminds the ophthalmologist to consider obtaining a fluorescein angiogram during follow-up after an intravitreal pegaptanib injection to monitor CNV lesion characteristics, particularly if the visual acuity decreases.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , ,